10 Best Micro Cap Stocks to Buy Now

Page 9 of 9

1. Acelyrin, Inc. (NASDAQ:SLRN)

Market Capitalization: $251.818 million

Acelyrin, Inc. (NASDAQ:SLRN) is a biopharma company focused on the development and commercialization of life-changing drug therapies. This California-based company, incorporated in July 2020, offers izokibep, which is currently in Phase III clinical trials for the treatment of Hidradenitis Suppurativa, Psoriatic Arthritis, and uveitis and in Phase II for the treatment of Axial Spondyloarthritis.

In recent news, Acelyrin, Inc. (NASDAQ:SLRN) announced a definitive merger agreement with California-based Alumis Inc., forming a late-stage clinical biopharmaceutical company. Eric Schmidt, an analyst at Cantor Fitzgerald, regarded the deal as “capital recycling at its best.” The proposed unit will specialize in innovating, developing, and commercializing new therapies for people living with immune-mediated diseases.

The transaction, scheduled to finalize in the second quarter of 2025, will allow both companies to leverage a distinguished late-stage therapies portfolio. Together, the combined business can capitalize on its record of successful R&D, coupled with proprietary data and analytics platforms. The pro forma cash position of approximately $737 million is adequate to meet the operating expenses and capital expenditure requirements into 2027.

Although the financials of the company reflect the lack of revenue, Acelyrin, Inc. (NASDAQ:SLRN) retains a strong cash position, with current assets surpassing liabilities, underscoring financial stability and current clinical advancements. While the revenue growth rate is expected to be around 77%, the earnings growth rate and EPS are anticipated to be around 23.8% and 28.8%, respectively. Keeping this in mind, the stock has an upside potential of 347%, as reported by analysts. SLRN is among the best micro-cap stocks to buy now.

Overall, Acelyrin, Inc. (NASDAQ:SLRN) ranks first on our list of the best micro-cap stocks to buy now. While we acknowledge the potential for SLRN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than SLRN but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stock To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 9 of 9